Lv4
554 积分 2024-03-26 加入
GPC3-specific dnTGFβRII-armoured CAR T cells for hepatocellular carcinoma
1个月前
已完结
GPC3-specific dnTGFβRII-armoured CAR T cells for hepatocellular carcinoma
1个月前
已完结
Outcomes of Y90-radioembolization as downstaging to liver transplantation in patients with hepatocellular carcinoma and tumoral portal vein thrombosis
2个月前
已完结
Reconsidering adjuvant and perioperative immune-checkpoint inhibition: de-escalation, expansion and personalization
2个月前
已完结
Adjuvant nivolumab in muscle-invasive urothelial carcinoma: exploratory biomarker analysis of the randomized phase 3 CheckMate 274 trial
2个月前
已完结
Programmed death ligand 1 expression in hepatocellular carcinoma: Relationship With clinical and pathological features
2个月前
已完结
Prognostic impact of programmed cell death 1 ligand 1 expression in human leukocyte antigen class I-positive hepatocellular carcinoma after curative hepatectomy
2个月前
已完结
Integrative proteogenomic analysis provides molecular insights and clinical significance in gallbladder cancer
2个月前
已完结
Proteogenomic characterization identifies clinically relevant subgroups of intrahepatic cholangiocarcinoma
2个月前
已完结
Daraxonrasib or Chemotherapy in Previously Treated Metastatic Pancreatic Cancer
2个月前
已完结
皖公网安备34019202002308
